CHINARES PHARMA (03320): KPC Pharmaceuticals, Inc.'s net profit for the first three quarters was 323 million yuan, a decrease of 35.76% year-on-year.
China Resources Pharmaceuticals (03320) announced the performance of Kun Medicine Group for the nine months ended September 30, 2025, with a total operating income...
CHINARES PHARMA (03320) released the performance of KPC Pharmaceuticals, Inc. for the nine months ending September 30, 2025, with a total operating revenue of 4.751 billion RMB, a decrease of 18.08% year-on-year; net profit of 323 million RMB, a decrease of 35.76% year-on-year.
Related Articles
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
Software crashed together? Roblox (RBLX.US): It has an ecological closed-loop, Genie can't break.
Industrial: Hong Kong stock market sentiment index has reached the bottom area.
"The 'Chinese Choice' for Global SiC Core Customers: Why TIANYU SEMI (02658)?"
RECOMMEND
Nine Companies With Market Value Over RMB 100 Billion Awaiting, Hong Kong IPO Boom Continues Into 2026
07/02/2026
Hong Kong IPO Cornerstone Investments Surge: HKD 18.52 Billion In First Month, Up More Than 13 Times Year‑On‑Year
07/02/2026
Over 400 Companies Lined Up For Hong Kong IPOs; HKEX Says Market Can Absorb
07/02/2026
